Riskpilot← Back to searchSign inGet full accessIVFERTILIZATION DEVICES ApS
APSActiveCVR 35040277Råbyovedvej 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 2013— employees
Revenue 2025
DKK 328K
+812% vs 2024
EBITDA margin
59.5%
+443% vs 2024
Equity ratio
79.9%
Financial strength
Net profit 2025
DKK 150K
+513% vs 2024
| Revenue | DKK 328K | +812% |
| EBITDA | DKK 195K | +443% |
| Net profit | DKK 150K | +513% |
| Total assets | DKK 533K | +78% |
| Equity | DKK 426K | +54% |
| Employees | — | — |
Legal name
IVFERTILIZATION DEVICES ApS
CVR number
35040277
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12. februar 2013
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening
Company purpose
Selskabets formål er at udvikle og sælge medicinsk udstyr og andre produkter og services indenfor IVF (In Vitro Fertilization) samt anden i forbindelse hermed stående virksomhed.
Address
Råbyovedvej 8
Phone
+4521445919
Email
jacm@mail.tele.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 146 | 48 | -105 | 147 | -43 | -23 | 50 | 86 | 39 | 32 | 36 | 328 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 146 | 48 | -105 | 147 | -43 | -23 | 50 | 86 | 39 | 32 | 36 | 195 |
| Depreciation & amort. | 15 | -19 | -19 | -19 | -19 | -19 | -19 | -7 | -7 | -7 | -3 | -0 |
| EBIT | 131 | 29 | -124 | 128 | -62 | -42 | 31 | 79 | 32 | 25 | 33 | 195 |
| Net financials | 0 | 0 | 0 | -0 | 0 | -0 | -0 | -3 | -3 | -3 | -2 | -3 |
| Profit before tax | 131 | 29 | -72 | 127 | -62 | -42 | 31 | 76 | 29 | 21 | 31 | 193 |
| Tax | 35 | 0 | 26 | 27 | -13 | -9 | 6 | 17 | 7 | 5 | 7 | 43 |
| Net profit | 96 | 29 | -98 | 101 | -49 | -33 | 25 | 59 | 22 | 16 | 24 | 150 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 223 | 249 | 129 | 253 | 191 | 150 | 167 | 241 | 277 | 282 | 300 | 533 |
| Equity | 181 | 209 | 111 | 212 | 163 | 130 | 155 | 214 | 235 | 251 | 276 | 426 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 | 14 | 17 | 24 | 24 | 20 | 12 | 24 | 39 | 29 | 24 | 107 |
| Total debt | 7 | 14 | 17 | 24 | 24 | 20 | 12 | 24 | 39 | 29 | 24 | 107 |
EBITDA margin
59.5%
This company
15.8%
Market median
+277% vs market
20142025
Equity ratio
79.9%
This company
38.2%
Market median
+109% vs market
20142025
Return on equity
35.2%
This company
18.4%
Market median
+91% vs market
20142025
Net profit margin
45.7%
This company
8.1%
Market median
+464% vs market
20142025
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20142025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-02-12 – 2014-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SB Founder | Founder | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Chairman | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bushøjgård ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bushøjgård ApS
IVFERTILIZATION DEVICES ApS Board members of IVFERTILIZATION DEVICES ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Broch Laursen | Founder | 0 companies |
| Jacob Møllenbach Larsen | Chairman | 0 companies |
| Lars Ploug Hansen | Chairman | 0 companies |